Cargando…

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters

SIMPLE SUMMARY: Our previous studies led us to hypothesize that downregulation of PLK1 expression or its activity can overcome the hurdles of taxane resistance by downregulating ABC transporters. Targeting PLK1 with shRNA or non-functional mutants downregulated ABCB1, ABCC9, and ABCG2 in paclitaxel-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Sol-Bi, Kim, Dae-Hoon, Kim, Da-Eun, Aldonza, Mark Borris D., Kim, Yoosik, Yim, Hyungshin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430738/ https://www.ncbi.nlm.nih.gov/pubmed/34503223 http://dx.doi.org/10.3390/cancers13174413

Ejemplares similares

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
por: Shin, Sol-Bi, et al.
Publicado: (2020)

Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021)

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021)

Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21(cip1) signaling in acute kidney injury
por: Kim, Da-Eun, et al.
Publicado: (2022)

PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC
por: Kim, Da-Eun, et al.
Publicado: (2023)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
por: Giordano, Antonio, et al.
Publicado: (2019)

Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)

Correction: Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)

Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass
por: Aldonza, Mark Borris D., et al.
Publicado: (2021)

Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
por: Aldonza, Mark Borris D., et al.
Publicado: (2020)

Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
por: Xu, Rong, et al.
Publicado: (2023)

SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
por: Langdon, Casey G., et al.
Publicado: (2015)

Molecular Targets of Genistein and Its Related Flavonoids to Exert Anticancer Effects
por: Chae, Hee-Sung, et al.
Publicado: (2019)

Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation
por: Aldonza, Mark Borris D, et al.
Publicado: (2017)

Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells
por: Tsaur, Igor, et al.
Publicado: (2022)

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy
por: Li, Zhenhua, et al.
Publicado: (2016)

The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas
por: Kim, Stefano, et al.
Publicado: (2015)

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interference
por: Chan, Lok Seng, et al.
Publicado: (2023)

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
por: Valinciute, Gintvile, et al.
Publicado: (2021)

Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
por: Valinciute, Gintvile, et al.
Publicado: (2023)

Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation
por: Aldonza, Mark Borris D., et al.
Publicado: (2016)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib
por: Eggermont, Carolien, et al.
Publicado: (2023)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Taxanes in the Treatment of Advanced Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2016)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

PLK1 plays dual roles in centralspindlin regulation during cytokinesis
por: Adriaans, Ingrid E., et al.
Publicado: (2019)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Multi-targeted therapy resistance via drug-induced secretome fucosylation
por: Aldonza, Mark Borris D, et al.
Publicado: (2023)

Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition
por: Shen, Ying, et al.
Publicado: (2015)

Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition
por: Xu, Rong, et al.
Publicado: (2019)

Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells
por: Aldonza, Mark Borris D., et al.
Publicado: (2017)

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
por: Kumar, Shiv, et al.
Publicado: (2015)

Dual Inhibition of γ-Tubulin and Plk1 Induces Mitotic Cell Death
por: Ebisu, Haruna, et al.
Publicado: (2021)

Isolation and Characterization of the Colletotrichum acutatum ABC Transporter CaABC1
por: Kim, Suyoung, et al.
Publicado: (2014)

Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option
por: Dietrich, Peter, et al.
Publicado: (2017)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

A novel dual-labeled small peptide as a multimodal imaging agent for targeting wild-type EGFR in tumors
por: Kim, Myoung Hyoun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ftt1nsu3gip97gmr2oir1v66o8